Role of a key enzyme in reducing heart disease ...(n avenues for the development of new the...),Health
Navigation Links
Role of a key enzyme in reducing heart disease identified
Date:10/24/2007
n avenues for the development of new therapies. By identifying CEH as a new therapeutic target, we expect that in the future patients with heart disease will have more options to aggressively treat heart disease. In addition, by determining the levels of CEH in human blood cells, we hope to be able to predict susceptibility to heart disease in the future, she said.
According to Ghosh, the team focused their efforts on the examination of macrophage foam cells, which are responsible for storing large amounts of cholesterol and lead to the clogging of the arteries by forming plaques. The findings appear in the October print issue of the Journal of Clinical Investigation.
The team is actively exploring the mechanisms underlying CEH regulation and to determine how its activity can be increased in order to reduce heart disease.
'/>"/>
| Contact: Sathya Achia-Abraham sbachia@vcu.edu 804-827-0890 Virginia Commonwealth University Source:Eurekalert |
Related medicine news :
1. Enzyme may be target for obesity drugs
2. Researchers trick Alzheimers Enzyme
3. Enzyme stimulates growth of adult stem cells
4. Enzyme may aid hold back disease
5. Coenzyme Q10 may reduce risk of Parkinsons disease
6. Enzyme help destroy cancer cell
7. Key enzyme protects against Alzheimers
8. Enzyme Associated with Memory
9. Enzyme Associated With Memory
10. Brain Enzyme Found To Regulate Weight
11. New Enzyme Identified For Arthritis
Post Your Comments:
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-USNew... urging senators to modify health care reform legi...guage regarding a health insurance individual cove... and enforceable mandate will minimize adverse sel...ting rules prescribed by the bill. ,, "The indi...
(Date:11/20/2009)..., , QUINCY, Mass., Nov. 20 ... Supermarket Company removed from sale Shedd,s Cou...oli Rice and Shedd,s Country Crock ® Side Dis...sulfite allergen. ,, The following code dates ...k ® Side Dishes DELUXE Cheddar Broccoli Rice ...
(Date:11/20/2009)..., , MADISON, N.J., Nov. 20 /PRNewswire-F...nfluenza virus may have peaked in late October, bu...al source of illness in all age groups, including ...agnostics Incorporated (NYSE: DGX ), the world,s...on and services. ,, In its most recent Quest D...
(Date:11/20/2009)..., , ST. LOUIS, Nov. 20 /PRNewswire-First...y announced that it will present at the Bank of Am...held December 2-3, 2009, at the Crowne Plaza Hotel... present Wednesday, December 2nd at 8:30 a.m. East...ay access a live, audio webcast of Centene,s prese...
(Date:11/20/2009)..., , WINSTON-SALEM, N.C., Nov. 20 /PRNewswir...t he is on a mission to redefine what it means to ...essional counselor with a specialty in family coun...t Wake Forest University, Gladding says research s...n leads to sadness and even depression during the ...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2[0] Actuaries to Senate: Strengthen Individual Mandate[0] Stop & Shop Alerts Customers to Voluntary Recall by Unilever[0] H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics[0] Centene Corporation to Present at Bank of America Merrill Lynch Credit Conference[0] Why Holidays Don't Have To Be 'Happy'
...shes between,rebels and government troops have cau...ic of Congo, International Medical Corps (IMC) con...s fleeing the fighting, while,working to maintain ...ing operations to,camps further south from the fig...
...tiva Health,Services, Inc. (Nasdaq: GTIV ), a lea...s, announced today that it plans to present at Nov... & Co., Credit Suisse and,Stephens Inc., The Comp...erence in New York. -- 4:30 p.m. to 4:55 p.m. MT...
...cies and standardization to personalize patient ...Calif., Oct. 30 Roche Molecular Diagnostics,today...n (FDA) has approved,the COBAS(R) AmpliPrep / COBA... RNA in a patient,s blood. Physicians use,Hepatiti...
...eals Nanoparticles Present in 4 out of 5,Sunscreen...S, N.Y., Oct. 30 Consumers Union,nonprofit publis...t tests,showing that 4 out of 5 sunscreens that cl...articles appear,widespread in mineral-based sunscr...
...rns top honors for a four-star ease of use ...s!, OAK BROOK, Ill., Oct. 30 Learning Curve,Bran...tion (Nasdaq: RCRC ),( http://www.learningcurve.c... a four-star Ease of Use rating. The C360 was,the ...
... MD Who Signed Prop 8 Ballot Argument, SACRAMENTO... released a statement signed by more than 300 lead...t opposition to Prop 8 and concluding,that the phy...statement took issue with Dr. Anderson, who identi...
Other Medicine News:Health News:International Medical Corps Continues Delivering Emergency Relief Amid Violence in Democratic Republic of Congo 2Health News:Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens 2Health News:Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens 3Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 2Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 3Health News:Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen 2Health News:The First Years True Fit C630 Convertible Car Seat Recieves Highest Given Rating From the National Highway Traffic Safety Administration 2Health News:NO on Prop 8 Campaign Releases Statement by 300 California Pediatricians 2International Medical Corps Continues Delivering Emergency Relief Amid Violence in Democratic Republic of CongoGentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and StephensRoche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR PlatformConsumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in SunscreenThe First Years True Fit C630 Convertible Car Seat Recieves Highest Given Rating From the National Highway Traffic Safety AdministrationNO on Prop 8 Campaign Releases Statement by 300 California Pediatricians
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...ire-FirstCall/ -- Smith & Nephew ( SNN, LSE: S...e signing of a technology development contract wit... lead to the creation of a fracture fixation syste...imbs of soldiers who sustain battlefield injuries....ojects Agency (DARPA), the central research and de...
(Date:11/19/2009)...wswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc...a public offering of 5,000,000 shares of its commo...ceeds of $48.75 million. All of the shares are be...helf registration statement previously filed with ...has also granted the underwriters a 30-day option ...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 1NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 2NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 3NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 4NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 5NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 6American Red Cross Charged With Bio Hazardous Waste Dumping 52159 1MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 1MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 2MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 3MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 4MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 5..., June 13 Disc Motion Technologies,announced the ...ant the,True Total Spinal Motion Segment System (T...ystem for the lumbar spine, featuring an artificia...device (PDS). The,successful procedure was perform...d Training Hospital by Dr. Erkan Kaptanoglu, Depar...
... at the European Cystic Fibrosis Society Conferenc...c., today,reported positive results from a Phase I... Arikace(TM) (liposomal amikacin for inhalation). ...of cystic fibrosis (CF),patients who have lung inf...a. The Phase II data indicated that Arikace, deliv...
Other Medicine Technology:Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device 2Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 2Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 3Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 4Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |